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As a relatively recent immigrant from Northern Eu-
rope, United Kingdom via the Netherlands, two countries
both benefitting from well organised clinical genetic ser-
vices, it is a great puzzle and worry to me why clinical ge-
netic services, particularly in the public sector, are so badly
organised in Brazil. Of course, the short answer is, the field
is grossly underfunded. But underlying that simplistic con-
clusion is the undeniable fact that the Brazilian Ministry of
Health at the federal level and various other bodies at the
state level have failed to recognise the public health care
value of establishing well-organised genetic screening and
counselling facilities. Although Brazil can be justly proud
of its health care position and initiatives in combating HIV
infection and poliomyelitis, amongst others, its record on
establishing well-organised and regulated genetic services
with appropriate attention to training and professional rec-
ognition of genetic counsellors, cytogeneticists, molecular
geneticists etc., falls far, far short of what is required and
would be acceptable in most other countries.
The de facto situation is that anybody with a medical
degree can put up a shingle claiming to carry out genetic di-
agnosis irrespective of training or specialist background.
This is a legal loophole, which does not do justice to the
technical requirements for genetic diagnosis and counsel-
ing or give professional recognition to the people really re-
quired to carry out the analyses, who are not usually not
medically qualified and learnt their trade in Biology and re-
lated areas. Further, the current situation does not require
diagnostic centres to provide evidence of proficiency, to
submit annual returns on productivity or participate in qual-
ity control trials. The rich, particularly in large conurba-
tions such as São Paulo, Porto Alegre, Rio de Janeiro etc.,
are well catered for by private clinics, albeit without any
traceable quality control by governmental agencies. Al-
though a few of the private laboratories take part in interna-
tional quality control programs, this is commercial window
dressing and at a national level undesirable. What self-
respecting Ministry of Health leaves it to foreign organisa-
tions to carry out the quality control work that they should
be performing themselves? In Brazil, the basic maxim is, if
you can pay for it, then you can get it. The vast majority of
the population are either excluded financially from making
use of private clinics, or are unaware of the health risks en-
suing from genetic disease or find great difficulty in finding
a centre prepared to undertake genetic investigation free of
charge. And even in situations where the government have
taken steps to provide genetic testing within the public sec-
tor, such as post-natal chromosome diagnosis, the estab-
lished level of remuneration is so low, that the diagnostic
laboratories cannot afford to carry out cytogenetic analyses
without a further source of income to cover the costs. Most
or all genetic diagnoses carried out in the public sector in
Brazil occur in public universities by people who are al-
ready overburdened by teaching and trying to do research,
let alone run a genetic service as well. Most receive no re-
muneration for this and their limited time is donated freely
to keep the services running. The bottom line is that the
available capacity is far too small for the number of re-
quests and only a small proportion of all applicants actually
receive attention within a short period of time. In short, ge-
netic testing within the public health care sector cannot and
never will take place adequately without extensive govern-
mental planning, reorganisation and introduction of ade-
quate financial incentives.
Chromosome prenatal diagnosis is now a well-
established procedure and passed out of the realms of being
experimental more than 15 years ago in most of the devel-
oped world. Why then should the GMB choose to publish
an article on this subject at this juncture (Kessler et al.,
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Editorial Comment
1 The writer is one of only two genetic diagnosticians to have been certified for both molecular genetic and cytogenetic diagnosis in the Netherlands. He was the chairman
of the Departments of Human Genetics within the medical schools of Leiden and subsequently Utrecht in the Netherlands and was a member of the Dutch ministry of
health committee that formulated the genetic health care plan practised in the Netherlands today. He helped negotiate the logistics of financing genetic services with the
health care insurers. He is not medically qualified.
2008)? There are two reasons for doing so: through lack of
any official avenue for cytogenetic centres to disclose pro-
ductivity and efficiency rates, the article permits this partic-
ular group from Porto Alegre to present its results on
carrying out chromosome prenatal diagnosis in the public
health-care sector and for the results to be evaluated by oth-
ers; secondly the article points to many of the inadequacies
in Brazilian genetic screening services, not from the point
of view of the efficiency of the Porto Alegre group itself,
which succeeded remarkably well under the circumstances,
but with the problems encountered on the way. Firstly,
there are very few centres performing chromosome prena-
tal diagnosis in the public sector and many of the patients
have to travel large distances. The work is specialised and
labour intensive. This group was fortunate in that their hos-
pital was prepared to fund the screening, probably account-
ing why the group could maintain its activities for the 18
year period described in the article. The lack of governmen-
tal financial support is one of the main reasons why so few
groups are active with chromosome prenatal screening,
despite an ever increasing need as physicians and the Bra-
zilian public at large become increasingly aware of the di-
agnostic possibilities. Of course this situation begs the
question of why one would even bother to carry out chro-
mosome prenatal diagnosis when induced abortion is still
illegal in Brazil and likely to remain so for a long period of
time, but not for ever. Even the prototypically Roman Cath-
olic country Italy legalised abortion 30 years ago despite
ongoing controversies and attempts to reverse the law to
this day. However, the straight answer for the current Bra-
zilian situation is that knowing before a baby is born that it
carries a chromosome abnormality, mentally prepares the
parents beforehand on what they can expect at either mis-
carriage or birth of their child. In countries where induced
abortion is legal, prenatal diagnosis is rarely refused even
when the parents announce before hand that whatever the
outcome, they will not have the child aborted: the parent’s
right to know what is in store for them is regarded as suffi-
cient grounds for carrying out chromosome prenatal diag-
nosis.
How can the Brazilian situation be improved? Since
2004 a working group, composed of members from the two
Brazilian Society of Genetics and Medical Genetics, re-
spectively, and technical staff from the Ministry of Health
have evaluated the potential need for genetic services na-
tion-wide and drawn up guidelines on minimal require-
ments for infrastructure and financial commitments. The
group also formulated a proposal for setting up a national
policy for clinical genetics in the public sector, which in-
cludes publicity campaigns on prevention and education di-
rected not only to the general public but also to health
professionals. The Ministry of Health should be responsi-
ble for setting up such policy as well as monitoring the
quality through annual reports. However, 4 years is a long
period of time and the crucial question is when will the
Ministry of Health finally start making use of the recom-
mendations of the committee and legalise implementation
of a Brazilian national program in genetic health care? I
would suggest also that, following implementation of the
plan the derived criteria of quality control and reporting
also be extended to the private sector and make them oblig-
atory for all private centres to stay in business. Only then,
will the Brazilian public at large start receiving the quality
of genetic health care that it is entitled to.
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